High-dose intravenous immunoglobulin therapy for refractory viral infection after allogeneic hematopoietic stem cell transplantation.
Not Applicable
- Conditions
- Refractory viremia with high viral load, viral infection and viral disease after allogeneic hematopoietic stem cell transplantation
- Registration Number
- JPRN-UMIN000003034
- Lead Sponsor
- Hematology, Osaka City University, Graduate School of Meicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 14
Inclusion Criteria
Not provided
Exclusion Criteria
1) History of allergic reaction to immunoglobulin preparations 2) History of severe adverse effect of immunoglobulin preparations 3) Presence of veno-occlusive disease (VOD) after allogeneic stem cell transplantation 4) Positivity of HIV-antibody, HCV-antibody, HBs-antigen, or HBV-DNA 5) No indication for this study judged by physician in charge
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method